Stephen J Russell, MD, PhD

  • 24608 Citations
  • 83 Scopus h-Index
1986 …2021

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2019

Oncolytic Measles Virotherapy and Opposition to Measles Vaccination

Russell, S. J., Babovic-Vuksanovic, D., Bexon, A., Cattaneo, R., Dingli, D., Dispenzieri, A., Deyle, D. R., Federspiel, M. J., Fielding, A., Galanis, E., Lacy, M. Q., Leibovich, B. C., Liu, M. C., Muñoz-Alía, M., Miest, T. C., Molina, J. R., Mueller, S., Okuno, S. H., Packiriswamy, N., Peikert, T. & 6 others, Raffel, C., Van Rhee, F., Ungerechts, G., Young, P. R., Zhou, Y. & Peng, K. W., Jan 1 2019, In : Mayo Clinic proceedings.

Research output: Contribution to journalReview article

Open Access
1 Scopus citations

Oncolytic Viruses: Priming Time for Cancer Immunotherapy

Russell, L., Peng, K. W., Russell, S. J. & Diaz, R. M., Jan 1 2019, In : BioDrugs.

Research output: Contribution to journalReview article

Open Access
6 Scopus citations
2018

Clinical trials with oncolytic measles virus: Current status and future prospects

Msaouel, P., Opyrchal, M., Dispenzieri, A., Peng, K-W., Federspiel, M. J., Russell, S. J. & Galanis, E., Jan 1 2018, In : Current Cancer Drug Targets. 18, 2, p. 177-187 11 p.

Research output: Contribution to journalReview article

21 Scopus citations

Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines

Russell, S. J. & Barber, G. N., Apr 9 2018, In : Cancer Cell. 33, 4, p. 599-605 7 p.

Research output: Contribution to journalReview article

29 Scopus citations
2017

Designing and building oncolytic viruses

Maroun, J., Muñoz-Alía, M., Ammayappan, A., Schulze, A., Peng, K-W. & Russell, S. J., Apr 1 2017, In : Future Virology. 12, 4, p. 193-213 21 p.

Research output: Contribution to journalReview article

34 Scopus citations

How to develop viruses into anticancer weapons

Cattaneo, R. & Russell, S. J., Mar 1 2017, In : PLoS Pathogens. 13, 3, e1006190.

Research output: Contribution to journalReview article

16 Scopus citations

Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy

Dingli, D. M., Ailawadhi, S., Bergsagel, P. L., Buadi, F. K., Dispenzieri, A., Fonseca, R., Gertz, M., Gonsalves, W., Hayman, S. R., Kapoor, P., Kourelis, T., Kumar, S. K., Kyle, R. A., Lacy, M., Leung, N., Lin, Y., Lust, J. A., Mikhael, J. R., Reeder, C. B., Roy, V. & 7 others, Russell, S. J., Sher, T., Stewart, A. K., Warsame, R., Zeldenrust, S. R., Rajkumar, S. V. & Chanan Khan, A. A., Apr 1 2017, In : Mayo Clinic Proceedings. 92, 4, p. 578-598 21 p.

Research output: Contribution to journalReview article

48 Scopus citations
2014

Heterogeneous delivery is a barrier to the translational advancement of oncolytic virotherapy for treating solid tumors

Miller, A. C. & Russell, S. J., Jul 29 2014, In : Virus Adaptation and Treatment. 6, 1, p. 11-31 21 p.

Research output: Contribution to journalReview article

10 Scopus citations
2013

Oncolytic vaccines

Elsedawy, N. B. & Russell, S. J., Oct 28 2013, In : Expert review of vaccines. 12, 10, p. 1155-1172 18 p.

Research output: Contribution to journalReview article

30 Scopus citations

Smoldering multiple myeloma requiring treatment: Time for a new definition?

Dispenzieri, A., Stewart, A. K., Chanan-Khan, A., Rajkumar, S. V., Kyle, R. A., Fonseca, R., Kapoor, P., Bergsagel, P. L., McCurdy, A., Gertz, M. A., Lacy, M. Q., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Reeder, C., Roy, V., Buadi, F., Dingli, D., Hayman, S. R., Leung, N. & 3 others, Lin, Y., Mikhael, J. & Kumar, S. K., Dec 19 2013, In : Blood. 122, 26, p. 4172-4181 10 p.

Research output: Contribution to journalReview article

56 Scopus citations
2012

Oncolytic virotherapy

Russell, S. J., Peng, K. W. & Bell, J. C., Jul 1 2012, In : Nature biotechnology. 30, 7, p. 658-670 13 p.

Research output: Contribution to journalReview article

685 Scopus citations
2010

Diagnosis and management of waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

Ansell, S. M., Kyle, R. A., Reeder, C. B., Fonseca, R., Mikhael, J. R., Morice, W. G., Bergsagel, P. L., Buadi, F. K., Colgan, J. P., Dingli, D., Dispenzieri, A., Greipp, P. R., Habermann, T. M., Hayman, S. R., Inwards, D. J., Johnston, P. B., Kumar, S. K., Lacy, M. Q., Lust, J. A., Markovic, S. N. & 13 others, Micallef, I. N. M., Nowakowski, G. S., Porrata, L. F., Roy, V., Russell, S. J., Detweiler Short, K. E., Stewart, A. K., Thompson, C. A., Witzig, T. E., Zeldenrust, S. R., Dalton, R. J., Rajkumar, S. V. & Gertz, M. A., Sep 2010, In : Mayo Clinic proceedings. 85, 9, p. 824-833 10 p.

Research output: Contribution to journalReview article

104 Scopus citations

Use of attenuated paramyxoviruses for cancer therapy

Lech, P. J. & Russell, S. J., Nov 1 2010, In : Expert review of vaccines. 9, 11, p. 1275-1302 28 p.

Research output: Contribution to journalReview article

40 Scopus citations
2009

Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways

Naik, S. & Russell, S. J., Sep 1 2009, In : Expert Opinion on Biological Therapy. 9, 9, p. 1163-1176 14 p.

Research output: Contribution to journalReview article

74 Scopus citations

Management of newly diagnosed symptomatic multiple myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines

Kumar, S. K., Mikhael, J. R., Buadi, F. K., Dingli, D., Dispenzieri, A., Fonseca, R., Gertz, M. A., Greipp, P. R., Hayman, S. R., Kyle, R. A., Lacy, M. Q., Lust, J. A., Reeder, C. B., Roy, V., Russell, S. J., Detweiler Short, K. E., Stewart, A. K., Witzig, T. E., Zeldenrust, S. R., Dalton, R. J. & 2 others, Rajkumar, S. V. & Bergsagel, P. L., Dec 2009, In : Mayo Clinic proceedings. 84, 12, p. 1095-1110 16 p.

Research output: Contribution to journalReview article

194 Scopus citations

MicroRNAs and the regulation of vector tropism

Kelly, E. J. & Russell, S. J., Jan 1 2009, In : Molecular Therapy. 17, 3, p. 409-416 8 p.

Research output: Contribution to journalReview article

73 Scopus citations
2008

Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth

Munguia, A., Ota, T., Miest, T. & Russell, S. J., May 1 2008, In : Gene Therapy. 15, 10, p. 797-806 10 p.

Research output: Contribution to journalReview article

41 Scopus citations

Measles virus as an oncolytic vector platform

Blechacz, B. & Russell, S. J., Jun 1 2008, In : Current Gene Therapy. 8, 3, p. 162-175 14 p.

Research output: Contribution to journalReview article

28 Scopus citations

The utility of cells as vehicles for oncolytic virus therapies

Russell, S. J. & Peng, K. W., Aug 1 2008, In : Current Opinion in Molecular Therapeutics. 10, 4, p. 380-386 7 p.

Research output: Contribution to journalReview article

27 Scopus citations
2007

Endocrine regulation of ageing

Russell, S. J. & Kahn, C. R., Sep 1 2007, In : Nature Reviews Molecular Cell Biology. 8, 9, p. 681-691 11 p.

Research output: Contribution to journalReview article

257 Scopus citations

Engineering targeted viral vectors for gene therapy

Waehler, R., Russell, S. J. & Curiel, D. T., Aug 3 2007, In : Nature Reviews Genetics. 8, 8, p. 573-587 15 p.

Research output: Contribution to journalReview article

459 Scopus citations

History of oncolytic viruses: Genesis to genetic engineering

Kelly, E. & Russell, S. J., Apr 1 2007, In : Molecular Therapy. 15, 4, p. 651-659 9 p.

Research output: Contribution to journalReview article

306 Scopus citations

Viruses as anticancer drugs

Russell, S. J. & Peng, K. W., Jul 1 2007, In : Trends in Pharmacological Sciences. 28, 7, p. 326-333 8 p.

Research output: Contribution to journalReview article

117 Scopus citations
2006

Enhancing the therapeutic index of radiation in multiple myeloma

Goel, A., Dispenzieri, A., Witzig, T. E. & Russell, S. J., Dec 1 2006, In : Drug Discovery Today: Disease Mechanisms. 3, 4, p. 515-522 8 p.

Research output: Contribution to journalReview article

3 Scopus citations
2004

Oncolytic measles viruses for cancer therapy

Nakamura, T. & Russell, S. J., Oct 1 2004, In : Expert Opinion on Biological Therapy. 4, 10, p. 1685-1692 8 p.

Research output: Contribution to journalReview article

48 Scopus citations

Parvovirus vectors: Use and optimisation in cancer gene therapy

Blechacz, B. & Russell, S. J., Jul 1 2004, In : Expert Reviews in Molecular Medicine. 6, 16

Research output: Contribution to journalReview article

10 Scopus citations
2003

A direct mechanical method for accurate and efficient adenoviral vector delivery to tissues

Khurana, V. G., Weiler, D. A., Witt, T. A., Smith, L. A., Kleppe, L. S., Parisi, J. E., Simari, R. D., O'Brien, T., Russell, S. J. & Katusic, Z. S., Mar 2003, In : Gene Therapy. 10, 5, p. 443-452 10 p.

Research output: Contribution to journalReview article

Open Access
12 Scopus citations

In Vivo Imaging and Tumor Therapy with the Sodium Iodide Symporter

Ding, D., Russell, S. J. & Morris, J. C., Dec 15 2003, In : Journal of cellular biochemistry. 90, 6, p. 1079-1086 8 p.

Research output: Contribution to journalReview article

70 Scopus citations

Targeting retroviral and lentiviral vectors

Sandrin, V., Russell, S. J. & Cosset, F. L., Aug 15 2003, In : Current Topics in Microbiology and Immunology. 281, p. 137-178 42 p.

Research output: Contribution to journalReview article

92 Scopus citations
2002

Lentiviral vector targeting

Larochelle, A., Peng, K. W. & Russell, S. J., Apr 9 2002, In : Current Topics in Microbiology and Immunology. 261, p. 143-163 21 p.

Research output: Contribution to journalReview article

7 Scopus citations

RNA viruses as virotherapy agents

Russell, S. J., Dec 1 2002, In : Cancer Gene Therapy. 9, 12, p. 961-966 6 p.

Research output: Contribution to journalReview article

122 Scopus citations
2001

Cancer gene therapy clinical trials: Lessons for the future

Galanis, E. & Russell, S., Nov 16 2001, In : British journal of cancer. 85, 10, p. 1432-1436 5 p.

Research output: Contribution to journalReview article

26 Scopus citations
105 Scopus citations

Retargeting gene delivery using surface-engineered retroviral vector particles

Lavillette, D., Russell, S. J. & Cosset, F. L., Oct 1 2001, In : Current Opinion in Biotechnology. 12, 5, p. 461-466 6 p.

Research output: Contribution to journalReview article

71 Scopus citations
2000

Cancer gene therapy: Hard lessons and new courses

Vile, R., Russell, S. J. & Lemoine, N. R., Jan 2000, In : Gene Therapy. 7, 1, p. 2-8 7 p.

Research output: Contribution to journalReview article

Open Access
185 Scopus citations
1999

Modifying the Host Range Properties of Retroviral Vectors

Russell, S. J. & Cosset, F. L., Jan 1 1999, In : Journal of Gene Medicine. 1, 5, p. 300-311 12 p.

Research output: Contribution to journalReview article

75 Scopus citations

Viral vector targeting

Peng, K. W. & Russell, S. J., Oct 1 1999, In : Current Opinion in Biotechnology. 10, 5, p. 454-457 4 p.

Research output: Contribution to journalReview article

56 Scopus citations
1997

Gene therapy for B cell lymphomas

Fielding, A. K. & Russell, S. J., Sep 15 1997, In : Cancer Surveys. 30, p. 327-342 16 p.

Research output: Contribution to journalReview article

5 Scopus citations
1996

Targeting retrovirus entry

Cosset, F. L. & Russell, S. J., Jan 1 1996, In : Gene Therapy. 3, 11, p. 946-956 11 p.

Research output: Contribution to journalReview article

108 Scopus citations

Vectors for cancer gene therapy

Zhang, J. & Russell, S. J., Jan 1 1996, In : Cancer and Metastasis Reviews. 15, 3, p. 385-401 17 p.

Research output: Contribution to journalReview article

33 Scopus citations
1995

Retroviruses as vectors

Vile, R. G. & Russell, S. J., Jan 1 1995, In : British Medical Bulletin. 51, 1, p. 12-30 19 p.

Research output: Contribution to journalReview article

108 Scopus citations